Partners Investment
96
16M
70
13.71
10
0.27
3
- Areas of investment
Summary
The venture was found in Asia in South Korea. The main office of represented VC is situated in the Seoul.
Deals in the range of 5 - 10 millions dollars are the general things for fund. Comparing to the other companies, this Partners Investment performs on 21 percentage points less the average number of lead investments. The fund is generally included in 2-6 deals every year. The higher amount of exits for fund were in 2018. Considering the real fund results, this VC is 12 percentage points less often commits exit comparing to other organizations. The average startup value when the investment from Partners Investment is 10-50 millions dollars. The top activity for fund was in 2016. Despite it in 2019 the fund had an activity.
Among the most successful fund investment fields, there are Business Development, Education. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Vedanta Biosciences, Bionetix, Moai Games For fund there is a match between the country of its foundation and the country of its the most frequent investments - South Korea. The fund has no exact preference in some founders of portfolio startups. When startup sums 3 of the founder, the probability for it to get the investment is little.
Besides them, we counted 4 critical employees of this fund in our database.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Partners Investment, startups are often financed by Partners Venture Capital, Softbank Ventures Asia, Samsung Ventures. The meaningful sponsors for the fund in investment in the same round are Softbank Ventures Asia, Korea Investment Partners, Timewise Investment. In the next rounds fund is usually obtained by Samsung Ventures, Formation 8, Softbank Ventures Asia.
Investments analytics
Analytics
- Total investments
- 96
- Lead investments
- 10
- Exits
- 3
- Rounds per year
- 13.71
- Follow on index
- 0.27
- Investments by industry
- Biotechnology (34)
- Health Care (19)
- Software (17)
- Gaming (11)
- Medical (9) Show 86 more
- Investments by region
-
- United States (23)
- South Korea (65)
- Singapore (1)
- Switzerland (1)
- Philippines (2) Show 3 more
- Peak activity year
- 2021
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 106M
- Group Appearance index
- 0.93
- Avg. company exit year
- 4
- Strategy success index
- 0.10
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Mustbio | 08 Dec 2022 | Biotechnology, Health Care, Medical | Early Stage Venture | 12M | Seoul, Seoul-t'ukpyolsi, South Korea |
Surginex | 27 Mar 2024 | Biotechnology, Genetics, Medical Device, Test and Measurement | Early Stage Venture | 7M | Seoul-t'ukpyolsi, Seocho, South Korea |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.